Extracellular Vesicle-Based Drug Delivery Systems for Head and Neck Squamous Cell Carcinoma: A Systematic Review

It is estimated that there are over 890,000 new cases of head and neck squamous cell carcinoma (HNSCC) worldwide each year, accounting for approximately 5% of all cancer cases. Current treatment options for HNSCC often cause significant side effects and functional impairments, thus there is a challe...

Descripción completa

Detalles Bibliográficos
Autores principales: Dżaman, Karolina, Czerwaty, Katarzyna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223025/
https://www.ncbi.nlm.nih.gov/pubmed/37242569
http://dx.doi.org/10.3390/pharmaceutics15051327

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10223025/
https://www.ncbi.nlm.nih.gov/pubmed/37242569
http://dx.doi.org/10.3390/pharmaceutics15051327

Ejemplares similares